Encompass Health director granted 1,634 RSUs

KATZ LESLYE G reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

KATZ LESLYE G reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Leslye G. Katz received an annual grant of 1,634 shares of Encompass Health Common Stock on May 7, 2026. The award was granted at no cash cost as restricted stock units under the company’s 2025 Omnibus Performance Incentive Plan.

Following this grant, Katz directly holds 49,558 shares of Encompass Health Common Stock. This is a routine equity compensation award rather than an open-market purchase or sale, so it does not reflect a discretionary trading decision in the company’s stock.

Insider Trade Summary

Grant/Award: 1,634 shares

Grant/Award 1 txn

Insider KATZ LESLYE G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	1,634	$0.00	$0.00

Holdings After Transaction: Encompass Health Common Stock — 49,558 shares (Direct)

Footnotes (1)

1. F1. Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

Key Figures

RSU grant size: 1,634 shares Grant price per share: $0.00 per share Shares held after grant: 49,558 shares +2 more

5 metrics

RSU grant size 1,634 shares Annual restricted stock unit grant on May 7, 2026

Grant price per share $0.00 per share Equity compensation grant, no cash paid

Shares held after grant 49,558 shares Total Encompass Health Common Stock directly owned after transaction

Transaction code A (acquisition) Grant, award, or other acquisition of non-derivative securities

Transaction date May 7, 2026 Date of RSU grant reported on Form 4

Key Terms

restricted stock units, 2025 Omnibus Performance Incentive Plan, Form 4, Grant, award, or other acquisition

4 terms

restricted stock units financial

"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2025 Omnibus Performance Incentive Plan financial

"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."

Form 4 regulatory

"INSIDER FILING DATA (Form 4): {"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Encompass Health (EHC) director Leslye G. Katz report on this Form 4?

Director Leslye G. Katz reported receiving an annual equity grant of 1,634 Encompass Health Common Stock shares. The award was structured as restricted stock units under the company’s 2025 Omnibus Performance Incentive Plan and did not involve any open-market buying or selling activity.

How many Encompass Health (EHC) shares did Leslye G. Katz receive in this grant?

Leslye G. Katz received 1,634 shares of Encompass Health Common Stock. These shares were granted as restricted stock units, representing part of her director compensation rather than a market purchase, and they increase her direct equity stake in the company accordingly.

What is Leslye G. Katz’s Encompass Health (EHC) share ownership after the reported grant?

After the grant, Leslye G. Katz directly holds 49,558 shares of Encompass Health Common Stock. This figure includes the newly granted 1,634 restricted stock units and reflects her updated direct ownership position as disclosed in the Form 4 filing.

Was there a purchase or sale of Encompass Health (EHC) shares on the open market?

No, there was no open-market purchase or sale. The Form 4 shows a grant coded as an acquisition (code A), representing a compensation-related award of restricted stock units rather than a voluntary buy or sell transaction in the public market.

Under which plan was the Encompass Health (EHC) equity award to Leslye G. Katz granted?

The equity award to Leslye G. Katz was granted under Encompass Health’s 2025 Omnibus Performance Incentive Plan. The footnote specifies it as an annual grant of restricted stock units provided as part of the company’s established director compensation framework.

On what date was the Encompass Health (EHC) restricted stock unit grant to Leslye G. Katz made?

The restricted stock unit grant to Leslye G. Katz was made on May 7, 2026. That transaction date is disclosed in the Form 4 and corresponds to the annual award provided under Encompass Health’s 2025 Omnibus Performance Incentive Plan for directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 11:34 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KATZ LESLYE G

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	05/07/2026		A		1,634(1)	A	$0	49,558	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

	/s/ Patrick Darby, attorney-in-fact for Leslye G. Katz	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)